Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
IEEE Trans Ultrason Ferroelectr Freq Control. 2011 Feb;58(2):305-15. doi: 10.1109/TUFFC.2011.1808.
The goal of this study is to develop a focal zone sharpening strategy that produces more precise lesions for pulsed cavitational ultrasound therapy, or histotripsy. Precise and well-confined lesions were produced by locally suppressing cavitation in the periphery of the treatment focus without affecting cavitation in the center. The local suppression of cavitation was achieved using cavitation nuclei preconditioning pulses to actively control cavitation in the periphery of the focus. A 1-MHz 513-element therapeutic array was used to generate both the therapy and the nuclei preconditioning pulses. For therapy, 10-cycle bursts at 100-Hz pulse repetition frequency with P-/P+ pressure of 21/76 MPa were delivered to the geometric focus of the therapeutic array. For nuclei preconditioning, a different pulse was delivered to an annular region immediately surrounding the focus before each therapy pulse. A parametric study on the effective pressure, pulse duration, and delivery time of the preconditioning pulse was conducted in red blood cell-gel phantoms, where cavitational damage was indicated by the color change resulting from local cell lysis. Results showed that a short-duration (20 μs) preconditioning pulse at a medium pressure (P-/P+ pressure of 7.2/13.6 MPa) delivered shortly before (30 μs) the therapy pulse substantially suppressed the peripheral damage by 77 ± 13% while complete fractionation in the focal center was maintained. High-speed imaging of the bubble cloud showed a substantial decrease in the maximum width of the bubble cloud by 48 ± 24% using focal zone sharpening. Experiments in ex vivo livers confirmed that highly confined lesions were produced in real tissues as well as in the phantoms. This study demonstrated the feasibility of active focal zone sharpening using cavitation nuclei preconditioning, allowing for increased treatment precision compared with the natural focal width of the therapy transducer.
这项研究的目的是开发一种焦域增强策略,为脉冲空化超声治疗(即 histotripsy)产生更精确的病变。通过在治疗焦点的外围局部抑制空化而不影响中心的空化,产生了精确且良好限制的病变。通过使用空化核预处理脉冲主动控制焦点外围的空化来实现空化的局部抑制。使用 1MHz 的 513 个元件治疗阵列来产生治疗和核预处理脉冲。对于治疗,以 100Hz 脉冲重复频率施加 10 个周期的突发,具有 21/76MPa 的 P-/P+压力,施加到治疗阵列的几何焦点。对于核预处理,在每个治疗脉冲之前,向焦点周围的一个环形区域发送一个不同的脉冲。在红细胞-凝胶仿体中进行了有效压力、脉冲持续时间和预处理脉冲传递时间的参数研究,其中空化损伤通过局部细胞裂解导致的颜色变化来表示。结果表明,在治疗脉冲之前短时间(30μs)施加短持续时间(20μs)、中等压力(7.2/13.6MPa 的 P-/P+压力)的预处理脉冲可使外围损伤显著抑制 77±13%,而焦点中心完全分离。气泡云的高速成像显示,使用焦域增强,气泡云的最大宽度显著减小了 48±24%。离体肝脏实验证实,在真实组织和仿体中都产生了高度限制的病变。这项研究证明了使用空化核预处理进行主动焦域增强的可行性,与治疗换能器的自然焦域宽度相比,可提高治疗精度。